T 0833/11 (Fluticasone furoate/GLAXO) of 08.04.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T083311.20140408
- Date of decision
- 8 April 2014
- Case number
- T 0833/11
- Petition for review of
- -
- Application number
- 01953272.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- 6.alpha.,9.alpha.-Difluoro-17.alpha.-(2-furanylcarbonyl)-oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
- Applicant name
- GLAXO GROUP LIMITED
- Opponent name
- NORTON HEALTHCARE LIMITED
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 111(1)European Patent Convention Art 114(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 16(1)
- Keywords
- Main request, allowable
Sufficiency (yes)
Novelty (yes), specific ester
Inventive step (yes), choice of closest prior art
Admission of late-filed document (no)
Apportionment of costs (no)
Remittal (no) - Catchword
- -
- Cited cases
- G 0001/03T 0181/82T 0256/87T 0967/97T 1046/97T 0591/04T 0365/07T 0608/07T 0021/08T 0593/09T 1760/11
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The request for apportionment of costs is rejected.